Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose isotretinoin plus 5% minoxidil foam for male androgenetic alopecia
ChiCTR2600129775Phase 4Completed
- Sponsor
- Dermatology Hospital of Jiangxi Province
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of isotretinoin and minoxidil in androgenetic alopecia (AGA), seborrheic dermatitis (SD), acne vulgaris and 1 more (2 arms), sponsored by Dermatology Hospital of Jiangxi Province. Primary endpoints: Hair growth density, Hair diameter variation rate and 4 more. Started Aug 2026; status: completed.
02
Drugs
isotretinoinminoxidil
03
Conditions
androgenetic alopecia (AGA)seborrheic dermatitis (SD)acne vulgarisfolliculitis
Beyond the preview
Go deeper on ChiCTR2600129775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129775.